| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 90 | 67 | 186 | 97 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 90 | 67 | 186 | 97 | 0 | 0 | 0 | 0 | 0 | 72.722 |
| Total Expenses - EUR | 82 | 58 | 173 | 92 | 384 | 57 | 133 | 13 | 90 | 51.521 |
| Gross Profit/Loss - EUR | 8 | 8 | 14 | 5 | -384 | -57 | -133 | -13 | -90 | 21.201 |
| Net Profit/Loss - EUR | 6 | 6 | 8 | 2 | -384 | -57 | -133 | -13 | -90 | 17.823 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Luca Royal Bio Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 11.680 | 13.337 | 13.154 | 12.905 | 12.619 | 12.658 | 12.620 | 57.872 |
| Current Assets | 555 | 556 | 283 | 555 | 187 | 131 | 136 | 143 | 143 | 18.068 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 140 | 137 | 134 | 131 | 132 | 131 | 244 |
| Cash | 555 | 556 | 283 | 416 | 50 | -4 | 5 | 12 | 12 | 17.824 |
| Shareholders Funds | -685 | -671 | -652 | -638 | -1.010 | -1.043 | -1.154 | -1.171 | -1.257 | 16.573 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.240 | 1.227 | 12.615 | 14.530 | 14.351 | 14.079 | 13.909 | 13.972 | 14.019 | 14.044 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45.323 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "121 - 121" | |||||||||
| CAEN Financial Year |
121
|
|||||||||
Comments - Luca Royal Bio Srl